SCHEMBL22270677

SCHEMBL22270677

CNc1ccc(-c2nccnc2NC(C)c2ccc(Cl)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATP1A1 P05023 1/20 0.43
▸ ATP1B1 P05026 1/20 0.43
▸ ATP1A3 P13637 1/20 0.43
▸ ATP1B2 P14415 1/20 0.43
▸ ATP1A2 P50993 1/20 0.43
▸ ATP1B3 P54709 1/20 0.43
▸ FXYD2 P54710 1/20 0.43
▸ ATP1A4 Q13733 1/20 0.43
▸ AKT1 P31749 3/20 0.39
▸ LDHA P00338 2/20 0.39
▸ LDHB P07195 1/20 0.39
▸ TRPV1 Q8NER1 2/20 0.38
▸ BDKRB1 P46663 1/20 0.38
▸ CAMK2D Q13557 1/20 0.37
▸ KDM4E B2RXH2 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ PTGDR2 Q9Y5Y4 1/20 0.36
▸ CNR1 P21554 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22270578 0.86 ALDH1A1 (0.47) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL19205734 0.85 ATP1A1 (0.44) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL19205733 0.85 ATP1A1 (0.44) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL22270670 0.85 DYRK1A (0.43) LDHALMNAP2RX3MAPTMAPK1
SCHEMBL22270638 0.80 TRPV1 (0.44) AKT1TRPV1KDM4EALDH1A1LMNA
SCHEMBL22270657 0.76 SOS1 (0.39) LMNAPTGDR2
SCHEMBL19205819 0.75 ATP1A1 (0.49) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL19205818 0.75 ATP1A1 (0.49) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL18484149 0.73 EGFR (0.45) LDHALDHBTRPV1BDKRB1KDM4E
SCHEMBL18484150 0.73 EGFR (0.45) LDHALDHBTRPV1BDKRB1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3686187-A1 PROCESS FOR THE PREPARATION OF ROR GAMMA MODULATORS Glenmark Pharmaceuticals S.A. (CH) 2020-07-29 — — EP disclosed
Send feedback